An investigation into signal transduction mechanisms involved in DHPG-induced LTD in the CA1 region of the hippocampus - PubMed (original) (raw)
An investigation into signal transduction mechanisms involved in DHPG-induced LTD in the CA1 region of the hippocampus
R Schnabel et al. Neuropharmacology. 1999 Oct.
Abstract
Previously, we have found that activation of mGlu receptors using a group I-specific mGlu receptor agonist, (RS)-3,5-DHPG, can induce long-term depression (LTD) in the CA1 region of the hippocampus and that, once established, this synaptic depression can be reversed by application of the mGlu receptor antagonist, (S)-MCPG [Palmer et al., 1997. Neuropharmacology 36, 1517-1532]. We have started to investigate the signal transduction mechanisms involved in these effects. Group I mGlu receptors couple to phospholipase C and therefore can activate protein kinase C and mobilise Ca2+ from intracellular stores. However, neither protein kinase C inhibitors (chelerythrine or Ro 31-8220) nor agents which deplete intracellular Ca2+ stores (thapsigargin or cyclopiazonic acid) were able to prevent DHPG-induced LTD. Furthermore, the ability of MCPG to reverse DHPG-induced LTD was not prevented by these compounds. These results suggest that it is unlikely that DHPG-induced LTD, or its reversal by MCPG, is produced via activation of either protein kinase C or by release of Ca2+ from intracellular stores.
Similar articles
- A CaMKII inhibitor, KN-62, facilitates DHPG-induced LTD in the CA1 region of the hippocampus.
Schnabel R, Palmer MJ, Kilpatrick IC, Collingridge GL. Schnabel R, et al. Neuropharmacology. 1999 Apr;38(4):605-8. doi: 10.1016/s0028-3908(98)00229-9. Neuropharmacology. 1999. PMID: 10221764 - DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists.
Fitzjohn SM, Kingston AE, Lodge D, Collingridge GL. Fitzjohn SM, et al. Neuropharmacology. 1999 Oct;38(10):1577-83. doi: 10.1016/s0028-3908(99)00123-9. Neuropharmacology. 1999. PMID: 10530819 - Glutamate receptors and synaptic plasticity: The impact of Evans and Watkins.
Collingridge GL, Abraham WC. Collingridge GL, et al. Neuropharmacology. 2022 Mar 15;206:108922. doi: 10.1016/j.neuropharm.2021.108922. Epub 2021 Dec 15. Neuropharmacology. 2022. PMID: 34919905 Review. - On long-term depression induced by activation of G-protein coupled receptors.
Bashir ZI. Bashir ZI. Neurosci Res. 2003 Apr;45(4):363-7. doi: 10.1016/s0168-0102(03)00002-6. Neurosci Res. 2003. PMID: 12657448 Review.
Cited by
- Extracellular signal-regulated protein kinase activation is required for metabotropic glutamate receptor-dependent long-term depression in hippocampal area CA1.
Gallagher SM, Daly CA, Bear MF, Huber KM. Gallagher SM, et al. J Neurosci. 2004 May 19;24(20):4859-64. doi: 10.1523/JNEUROSCI.5407-03.2004. J Neurosci. 2004. PMID: 15152046 Free PMC article. - Separate Ionotropic and Metabotropic Glutamate Receptor Functions in Depotentiation vs. LTP: A Distinct Role for Group1 mGluR Subtypes and NMDARs.
Latif-Hernandez A, Faldini E, Ahmed T, Balschun D. Latif-Hernandez A, et al. Front Cell Neurosci. 2016 Nov 7;10:252. doi: 10.3389/fncel.2016.00252. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27872582 Free PMC article. - mGluR1/5-dependent long-term depression requires the regulated ectodomain cleavage of neuronal pentraxin NPR by TACE.
Cho RW, Park JM, Wolff SB, Xu D, Hopf C, Kim JA, Reddy RC, Petralia RS, Perin MS, Linden DJ, Worley PF. Cho RW, et al. Neuron. 2008 Mar 27;57(6):858-71. doi: 10.1016/j.neuron.2008.01.010. Neuron. 2008. PMID: 18367087 Free PMC article. - Interaction between Ephrins and mGlu5 metabotropic glutamate receptors in the induction of long-term synaptic depression in the hippocampus.
Piccinin S, Cinque C, Calò L, Molinaro G, Battaglia G, Maggi L, Nicoletti F, Melchiorri D, Eusebi F, Massey PV, Bashir ZI. Piccinin S, et al. J Neurosci. 2010 Feb 24;30(8):2835-43. doi: 10.1523/JNEUROSCI.4834-09.2010. J Neurosci. 2010. PMID: 20181581 Free PMC article. - β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X.
Stoppel LJ, Auerbach BD, Senter RK, Preza AR, Lefkowitz RJ, Bear MF. Stoppel LJ, et al. Cell Rep. 2017 Mar 21;18(12):2807-2814. doi: 10.1016/j.celrep.2017.02.075. Cell Rep. 2017. PMID: 28329674 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous